Metabiomics Corp
Early-stage molecular diagnostics company developing non-invasive microbiome-based in vitro diagnostic and screening tests for colorectal polyps, colorectal cancer, and other gastrointestinal diseases. Uses high-throughput DNA sequencing, multiplexed sample barcoding, computational systems biology, bioinformatics, and machine learning to discover microbial biomarkers, run IRB-approved clinical studies, and advance diagnostic assays. Maintains an intellectual property portfolio, published clinical evidence, and collaborations with academic and industry partners.
Industries
Nr. of Employees
small (1-50)
Metabiomics Corp
Carlsbad, California, United States, North America
Products
LifeKit® Prevent Colorectal Neoplasia Test
A non-invasive stool test that detects microbial DNA biomarkers to identify colon polyps and early-stage colorectal cancer.
MultiTag™ Sequencing Technology
A patented DNA sequencing method that enables amplification bias-free barcoding for high-throughput metagenomic analysis of multiple patient samples simultaneously.
Stool Sampling Kits for Microbiome Testing
Kits designed to collect and preserve stool samples for microbial DNA analysis, enabling non-invasive shipment without refrigeration.
Microbiome Characterization Services
Services for analyzing and characterizing gut microbiome health and disease using next-generation sequencing and computational biology.
LifeKit® Prevent Colorectal Neoplasia Test
A non-invasive stool test that detects microbial DNA biomarkers to identify colon polyps and early-stage colorectal cancer.
MultiTag™ Sequencing Technology
A patented DNA sequencing method that enables amplification bias-free barcoding for high-throughput metagenomic analysis of multiple patient samples simultaneously.
Stool Sampling Kits for Microbiome Testing
Kits designed to collect and preserve stool samples for microbial DNA analysis, enabling non-invasive shipment without refrigeration.
Microbiome Characterization Services
Services for analyzing and characterizing gut microbiome health and disease using next-generation sequencing and computational biology.
Services
Development of microbiome-based diagnostic assays
R&D and clinical development of non-invasive in vitro diagnostic assays that use microbial biomarkers to detect colorectal polyps and early-stage colorectal cancer.
Microbiome sequencing and analysis services
High-throughput microbial DNA sequencing workflows with multiplexed barcoding and downstream bioinformatics for research and clinical studies.
Clinical research collaborations and study support
Partnerships with medical institutions for IRB-approved studies, sample collection, data analysis, and clinical validation of microbiome diagnostics.
Sampling kit development and distribution
Development, evaluation, and distribution of stool and rectal sampling kits designed to preserve nucleic acids for microbiome analysis and enable ambient shipping.
Development of microbiome-based diagnostic assays
R&D and clinical development of non-invasive in vitro diagnostic assays that use microbial biomarkers to detect colorectal polyps and early-stage colorectal cancer.
Microbiome sequencing and analysis services
High-throughput microbial DNA sequencing workflows with multiplexed barcoding and downstream bioinformatics for research and clinical studies.
Clinical research collaborations and study support
Partnerships with medical institutions for IRB-approved studies, sample collection, data analysis, and clinical validation of microbiome diagnostics.
Sampling kit development and distribution
Development, evaluation, and distribution of stool and rectal sampling kits designed to preserve nucleic acids for microbiome analysis and enable ambient shipping.
Expertise Areas
- Microbiome diagnostics
- Clinical study design and execution for diagnostic validation
- Biomarker discovery and statistical validation
- Next-generation sequencing assay development and laboratory operations
Key Technologies
- Next-generation sequencing (NGS)
- Multiplexed sample barcoding
- 16S rRNA amplicon sequencing
- Shotgun metagenomic sequencing